(NASDAQ:AMLX) shares are up 20% again in pre-market trading on news of the FDA extending the review timeline of it’s new drug application. Shares are trading at $11.94 a share on more than 7,000 trades.
Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.
24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.